GLSI EBITDA Growth
Greenwich Lifesciences Inc · EBITDA Growth
GLSI EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-24.06%period ending
GLSI TTM EBITDA YoY % (77.49% → -24.06%)
Year-over-year change
High-resolution chart · PNG
GLSI ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -24.0598% | |
| -35.4949% | |
| -19.3704% | |
| -80.7086% | |
| -71.0794% | |
| -73.8408% | |
| -77.5974% | |
| -17.4626% | |
| -15.3015% | |
| -15.7904% | |
| -13.6361% | |
| -20.8358% | |
| -49.2475% | |
| -34.3006% | |
| -71.1305% | |
| -119.8824% | |
| -115.4235% | |
| -168.0137% | |
| -145.7047% | |
| -221.7371% | |
| -145.145% | |
| 36.9984% | |
| 45.6356% | |
| 77.4864% |